Immediate Impact
1 by Nobel laureates 65 standout
Citing Papers
Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Erin Twohy being referenced
BACCI: A phase II randomized, double-blind, multicenter, placebo-controlled study of capecitabine (C) bevacizumab (B) plus atezolizumab (A) or placebo (P) in refractory metastatic colorectal cancer (mCRC): An ACCRU network study
2019
A phase 1 and randomized, placebo‐controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Erin Twohy | 116 | 141 | 134 | 18 | 371 | |
| Sydney Kofman | 70 | 99 | 161 | 16 | 377 | |
| Patrizia Lastella | 133 | 74 | 132 | 22 | 372 | |
| Celia Mor | 80 | 131 | 111 | 25 | 394 | |
| Antonio Cremades | 65 | 128 | 141 | 23 | 377 | |
| A. M. Stark | 146 | 126 | 132 | 15 | 392 | |
| Roberta Migliorati | 92 | 66 | 65 | 30 | 329 | |
| Eunji Jo | 66 | 184 | 157 | 18 | 403 | |
| Fabien Calcagno | 107 | 89 | 92 | 30 | 409 | |
| Cinzia Candiotto | 115 | 88 | 48 | 9 | 365 | |
| Isabelle Tennevet | 140 | 125 | 169 | 20 | 374 |
All Works
Login with ORCID to disown or claim papers
Loading papers...